Locations
Cleveland, OH, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2016
Convelo Therapeutics is pioneering a new era in multiple sclerosis care through patented remyelination enhancing therapies. Founded by leading researchers from Case Western Reserve University, the company focuses on developing innovative medicines that actively repair and restore myelin in the central nervous system. Their unique drug discovery platform targets the myelination pathway, aiming for tangible patient outcomes rather than mere symptom management. With a strong leadership team and strategic partnerships, Convelo is positioned to make significant advancements in the treatment of neurological disorders, particularly multiple sclerosis, and has garnered attention through successful funding rounds and collaborations with major institutions.
Something looks off?